-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Ligand Pharmaceuticals Inc quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
- Ligand Pharmaceuticals Inc Deferred Tax Assets, Net of Valuation Allowance for the quarter ending December 31, 2023 was $46.1M, a 13.9% decline year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)